AGP Executive Report
Last update: 10 hours agoCancer Research: A pooled analysis of 1.5M adults links sugar-sweetened drinks to higher liver cancer risk (HCC and ICC), while artificially sweetened beverages showed no clear independent link—researchers urge cutting SSBs. End-of-Life Law: France’s National Assembly gave final approval to a bill legalizing euthanasia and assisted dying for some adults with incurable conditions, with a Constitutional Council review now pending. Public Health & Climate: Europe’s heat is driving excess deaths and exposing housing gaps; WHO flagged 1,300+ temperature-linked excess deaths since June 21, as desert dust and particulate pollution also rise. Respiratory Care: Real-world REACH data finds Broncho-Vaxom (OM-85) cuts recurrent respiratory infection rates by roughly 28–38% at 12 months and 29–41% at 24 months. Weight Management: The European Commission approved Novo Nordisk’s once-daily oral Wegovy (semaglutide) for EU adults with obesity or overweight plus conditions. Healthcare Policy: EU urged Portugal to tackle healthcare workforce shortages and housing affordability as part of 2026 Semester recommendations. Industry & Biotech: New analysis says Europe is widening its biomanufacturing lead over the US, helped by stronger incentives. Medical Tech: Siemens Healthineers will invest ~€70M to expand its Kemnath, Germany site for radiotherapy component production.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
